The Business Research Company’s Immunoassay Biomarker Test Menu Expansion Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035
LONDON, GREATER LONDON, UNITED KINGDOM, July 2, 2026 /EINPresswire.com/ — “The immunoassay biomarker test menu expansion market is gaining significant traction as advancements in diagnostic technologies and healthcare needs continue to evolve. This sector is witnessing rapid growth fueled by increasing disease prevalence and innovations that improve early detection and disease management. Let’s explore the current market size, the key factors driving this expansion, regional dynamics, and emerging trends shaping the future.
Steady Growth Trajectory of the Immunoassay Biomarker Test Menu Expansion Market
The market for immunoassay biomarker test menu expansion has shown remarkable progress recently. It is projected to increase from $0.53 billion in 2025 to $0.6 billion in 2026, growing at a compound annual growth rate (CAGR) of 12.2%. This surge during the historical period owes much to the rising incidence of chronic and infectious diseases, wider adoption of immunoassay-based diagnostics in clinical labs, the strengthening of hospital diagnostic infrastructures, and heightened awareness around early disease detection and preventive healthcare. Additionally, increased government funding aimed at diagnostic research and laboratory modernization has been a significant contributor to this growth.
Download a free sample of the immunoassay biomarker test menu expansion market report:
https://www.thebusinessresearchcompany.com/sample_request?id=73346966&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Jun_PR
Future Outlook and Market Size Forecast for Immunoassay Biomarker Test Menu Expansion
Looking ahead, the market is expected to expand even more rapidly, reaching $0.95 billion by 2030 with an anticipated CAGR of 12.4%. Factors contributing to this forecasted growth include the growing demand for precision medicine and personalized biomarker profiling, as well as the accelerated integration of AI and automation in diagnostic workflows. The widening adoption of multiplex and high-throughput testing platforms, along with the expansion of companion diagnostics in drug development processes, will also play vital roles. Moreover, increased focus on early detection programs for cancer and chronic illnesses is set to further boost market growth.
What Immunoassay Biomarker Test Menu Expansion Entails
Immunoassay biomarker test menu expansion involves broadening the range of biomarkers detectable through immunoassay techniques. This can be achieved by developing new assays or enhancing existing tests, ultimately improving diagnostic accuracy and disease monitoring. As a result, laboratories and healthcare providers can offer more comprehensive testing options, enabling timely and precise clinical decisions.
View the full immunoassay biomarker test menu expansion market report:
https://www.thebusinessresearchcompany.com/report/immunoassay-biomarker-test-menu-expansion-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Jun_PR
Increasing Burden of Chronic Diseases as a Market Driver
One of the major factors propelling the immunoassay biomarker test menu expansion market is the rising prevalence of chronic and lifestyle-related diseases. Conditions such as heart disease, diabetes, obesity, and hypertension are becoming more common due to aging populations and lifestyle risk factors like poor nutrition and lack of exercise. These long-term illnesses require ongoing monitoring, thereby increasing the need for expanded biomarker testing to facilitate early diagnosis and effective disease management.
Supporting Evidence for Demand Driven by Chronic Diseases
For instance, in April 2025, the US Centers for Disease Control and Prevention reported that in 2023, 76.4% of US adults had at least one chronic condition, translating to over 194 million individuals requiring continuous health monitoring. This growing patient population underscores the critical need for immunoassay biomarker test menu expansion, as it enables laboratories to identify a broader spectrum of disease-related biomarkers, significantly enhancing diagnostic capabilities.
Dominance and Growth Outlook by Region in the Immunoassay Biomarker Test Menu Expansion Market
In 2025, North America held the largest share of the immunoassay biomarker test menu expansion market. However, the Asia-Pacific region is forecasted to emerge as the fastest-growing market over the coming years. The market study encompasses major regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, and the Middle East and Africa, providing a comprehensive global perspective on market trends and opportunities.
New strategic additions in our 2026 market reports include market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company – www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company“
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
